Skip to main content

Advertisement

Log in

Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background

Lymphatic malformations (LMs) are congenital lesions of the lymphatic system and consist of lymphatic channels and cystic spaces of varying sizes. Recent evidence has shown that LMs respond well to intralesional sclerotherapy.

Objective

The purpose of this retrospective study is to evaluate the outcome and efficacy of using doxycycline in treating macrocystic, microcystic and combined macro- and microcystic LMs in a tertiary-care pediatric center.

Materials and methods

Fifty children (32 boys, 18 girls) underwent doxycycline sclerotherapy for treatment of LMs between January 2005 and October 2010. Demographics, imaging, doxycycline treatment details, complications and follow-up details were documented.

Results

The mean age at first treatment was 5.9 years (3 days–17.8 years), median 4.2 years. Cervicofacial (19/50 children) and truncal (16/50 children) locations were the most frequently affected. One hundred forty-six sclerotherapy sessions were performed in 50 children (mean 2.9/child). The mean doxycycline dose/kg body weight for 146 sessions was 15.3 mg/kg (0.6–85.7 mg/kg). Complications occurred in 4/146 procedures. Clinical follow-up showed excellent response in 14/16 children with macrocystic LMs, 21/27 children with combined LMs and 4/7 children with microcystic LMs.

Conclusion

Doxycycline is a safe and effective sclerosant agent for treating LMs in children, with a low complication rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Okazaki T, Iwatani S, Yanai T et al (2007) Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 42:386–389

    Article  PubMed  Google Scholar 

  2. Shiels WE, Kenney BD, Caniano DA et al (2008) Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 43:136–139

    Article  PubMed  Google Scholar 

  3. Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin N Am 37:435–474

    Article  Google Scholar 

  4. Giguère CM, Bauman NM, Smith RJ (2002) New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 111:1066–1075

    PubMed  Google Scholar 

  5. Alqahtani A, Nguyen LT, Flageole H et al (1999) 25 years’ experience with lymphangiomas in children. J Pediatr Surg 34:1164–1168

    Article  PubMed  CAS  Google Scholar 

  6. Nehra D, Jacobson L, Barnes P et al (2008) Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 43:451–460

    Article  PubMed  Google Scholar 

  7. Burrows PE, Mitri RK, Alomari A et al (2008) Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6:209–216

    Article  PubMed  CAS  Google Scholar 

  8. Cordes BM, Seidel F, Sulek M et al (2007) Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations. Otolaryngol Head Neck Surg 137:962–964

    Article  PubMed  Google Scholar 

  9. Dubois J, Garel L, Abela A et al (1997) Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 204:651–654

    PubMed  CAS  Google Scholar 

  10. Lee BB, Kim YW, Seo JM et al (2005) Current concepts in lymphatic malformation. Vasc Endovasc Surg 39:67–81

    Article  CAS  Google Scholar 

  11. Ogita S, Tsuto T, Nakamura K et al (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784–785

    Article  PubMed  CAS  Google Scholar 

  12. Kim KH, Sung M, Roh J et al (2004) Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 131:307–316

    Article  PubMed  Google Scholar 

  13. Niramis R, Watanatittan S, Rattanasuwan T (2010) Treatment of cystic hygroma by intralesional bleomycin injection: experience in 70 patients. Eur J Pediatr Surg 20:178–182

    Article  PubMed  CAS  Google Scholar 

  14. Shiels WE, Kang R, Murakami JW et al (2009) Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 141:219–224

    Article  PubMed  Google Scholar 

  15. Caliendo MV, Lee DE, Queiroz R et al (2001) Sclerotherapy with use of doxycycline after percutaneous drainage of postoperative lymphoceles. J Vasc Interv Radiol 12:73–77

    Article  PubMed  CAS  Google Scholar 

  16. Folk JJ, Musa AG (1995) Management of persistent lymphocele by sclerotherapy with doxycycline. Eur J Obstet Gynecol Reprod Biol 60:191–193

    Article  PubMed  CAS  Google Scholar 

  17. Robinson LA, Fleming WH, Galbraith TA (1993) Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 55:1115–1121

    Article  PubMed  CAS  Google Scholar 

  18. Suskind DL, Tavill MA, Handler SD (2000) Doxycycline sclerotherapy of benign lymphoepithelial cysts of the parotid: a minimally invasive treatment. Int J Pediatr Otorhinolaryngol 52:157–161

    Article  PubMed  CAS  Google Scholar 

  19. Tang S, Sreenarasimhaiah J, Tang L et al (2007) Endoscopic injection sclerotherapy with doxycycline for mediastinal and esophageal lymphangiohemangioma. Gastrointest Endosc 66:1196–1200

    Article  PubMed  Google Scholar 

  20. Lass A, Brinsden P (1999) The role of ovarian volume in reproductive medicine. Hum Reprod Update 5:256–266

    Article  PubMed  CAS  Google Scholar 

  21. Sacks D, McClenny TE, Cardella JF et al (2003) Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202

    Article  PubMed  Google Scholar 

  22. Emran MA, Dubois J, Laberge L et al (2006) Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children. J Pediatr Surg 41:975–979

    Article  PubMed  Google Scholar 

  23. Molitch HI, Unger EC, Witte CL et al (1995) Percutaneous sclerotherapy of lymphangiomas. Radiology 194:343–347

    PubMed  CAS  Google Scholar 

  24. Alomari AI, Karian VE, Lord DJ et al (2006) Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 17:1639–1648

    Article  PubMed  Google Scholar 

  25. Hurewitz AN, Lidonicci K, Wu CL et al (1994) Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest 106:1241–1245

    Article  PubMed  CAS  Google Scholar 

  26. Kirse DJ, Suen JY, Stern SJ et al (1996) Histologic effect of doxycycline sclerotherapy on rat femoral nerve. Head Neck 18:506–511

    Article  PubMed  CAS  Google Scholar 

  27. Hoff DS, Gremmels DB, Hall KM et al (2007) Dosage and effectiveness of intrapleural doxycycline for pediatric postcardiotomy pleural effusions. Pharmacotherapy 27:995–1000

    Article  PubMed  CAS  Google Scholar 

  28. Volovitz B, Shkap R, Amir J et al (2007) Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila) 46:121–126

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joao G. Amaral.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shergill, A., John, P. & Amaral, J.G. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 42, 1080–1088 (2012). https://doi.org/10.1007/s00247-012-2406-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-012-2406-2

Keywords

Navigation